News & Announcements

Microscope

NATICK, MA – August 12, 2020 – PIC Therapeutics (“PIC”), a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation, today announced the appointment of Katherine Bowdish, Ph.D., as its President and Chief Executive Officer. Dr. Bowdish will also join the Board of Directors of PIC.

BOSTON--(BUSINESS WIRE)--APRIL 15, 2020: PIC Therapeutics (“PIC”), a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation, closed a $5M Series Seed round of preferred equity funding.

Pipetting Samples